Convergent Therapeutics Announces First Shipments of Actinium 225 from Cardinal Health to Support the CONVERGE-01 Phase 2 Clinical Trial
| SCCUX Fund | USD 11.23 0.02 0.18% |
Slightly above 62% of Invesco Low's investor base is looking to short. The analysis of overall sentiment of trading Invesco Low Volatility mutual fund suggests that many investors are alarmed at this time. Invesco Low's investing sentiment can be driven by a variety of factors including economic data, Invesco Low's earnings reports, geopolitical events, and overall market trends.
Invesco |
Convergent Therapeutics Inc., a clinical stage biotechnology company focused on developing next generation radiopharmaceutical therapies for the treatment of prostate cancer and other cancers, today announced the receipt of the first shipments of non-carrier added Actinium 225 from Cardinal Health.
Read at finance.yahoo.com
 |
Invesco Low Fundamental Analysis
We analyze Invesco Low's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Invesco Low using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Invesco Low based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Invesco Low is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Invesco Low Volatility Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Invesco Low mutual fund to make a market-neutral strategy. Peer analysis of Invesco Low could also be used in its relative valuation, which is a method of valuing Invesco Low by comparing valuation metrics with similar companies.
Peers
Invesco Low Related Equities
| REINX | Invesco Real | 0.54 | ||||
| AMHYX | Invesco High | 0.28 | ||||
| VMICX | Invesco Municipal | 0.25 | ||||
| VMIIX | Invesco Municipal | 0.25 | ||||
| VMINX | Invesco Municipal | 0.17 | ||||
| OARDX | Oppenheimer Rising | 0.18 |
Other Information on Investing in Invesco Mutual Fund
Invesco Low financial ratios help investors to determine whether Invesco Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Invesco with respect to the benefits of owning Invesco Low security.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |